Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-412-0 | CAS number: 106-58-1
PBT assessment
Administrative data
PBT assessment: overall result
- Name:
- 1,4-dimethylpiperazine
- Type of composition:
- legal entity composition of the substance
- State / form:
- liquid
- Reference substance:
- 1,4-dimethylpiperazine
- PBT status:
- the substance is not PBT / vPvB
- Justification:
The information for the PBT assessment is currently being updated according to the ECHA Final Decision CCH-D-2114571346-45-01/F (deadline 11-01-2024).
An evaluation of the inherent properties of 1,4-dimethylpiperazine is performed against the ANNEX XIII criteria. If insufficient data were available, the screening criteria as laid down in ECHA Guidance on information requirements and chemical safety assessment Chapter R.11: PBT Assessment (2008) were applied.
1,4-dimethylpiperazine is considered not readily biodegradable according to an OECD 301 C study (Huntsman, 2008). Adaptations of micro-organisms is an important process for the degradation rate of 1,4-dimethylpiperazine in the environment. Results from a OECD 301 B study (BASF, 1996) indicate that 1,4-dimethylpiperazine show enhanced biodegradability under acclimated test conditions. Therefore, although the substance is concluded to be not readily biodegradable in an OECD 301C study, the substance should not be classified as persistent (P and vP).
The available evidence on bioaccumulation potential for 1,4-dimethylpiperazine indicates that the screening criteria for bioaccumulation potential (B and vB) are not met. Based on a low log Kow of -0.26, a low BCF can be estimated. In addition based on toxicokinetic information, a high bioaccumulation in mammals is not expected. Since the log Kow of the substance is < 4.5, the screening criteria for bioaccumulation are not fulfilled and 1,4 dimethylpiperazine is concluded not to have a bioaccumulative potential (not B / not vB).
Finally, because the substance does not fulfill the screening criteria based on acute toxicity for being considered as T, and does not fulfill two of the three Annex XIII criteria (classification for hazardous properties for human health), enough evidence is available for concluding that the substance is not T.
Based on the above, 1,4-dimethylpiperazine should not be considered as a PBT/vPvB substance.
Reference
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
